Mission Pharmacal Company-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Mission Pharmacal Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013445
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mission Pharmacal Company (Mission Pharmacal) is a pharmaceutical company, which develops, manufactures and markets prescription, over-the-counter, and dietary supplement products. It offers products for conditions related to women’s health, urology, pediatrics, and dermatology, among others. The company also offers contract manufacturing services. Mission Pharmacal has manufacturing and packaging capabilities to produce products in various forms such as powders, tablets, solutions, creams, lotions, gels and suspensions. It operates in the US and international markets through its distribution and sales network. The company has a manufacturing facility in Texas, with capabilities such as warehousing, manufacturing, and research and development. Mission Pharmacal is headquartered in San Antonio, Texas, the US.

Mission Pharmacal Company – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mission Pharmacal Company, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Mission Pharmacal Company, Medical Devices Deals, 2011 to YTD 2017 9
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Espada Dermatology Acquires GlyDerm from Lautus Pharma 11
Mission Pharmacal Acquires Eletone Cream From Ferndale Healthcare 12
Partnerships 13
DARA BioSciences Enters into Co-Promotion Agreement with Mission Pharmacal 13
Meda Enters Promotion Agreement With Mission Pharmacal For Elestrin 14
Licensing Agreements 15
Retrophin Amends Licensing Agreement with Mission Pharmacal for Thiola 15
EffRx Pharma Enters Into Licensing Agreement With Mission Pharmacal For Binosto 16
Acquisition 17
Mission Pharmacal Acquires ProSolus Pharma 17
Mission Pharmacal Company – Key Competitors 18
Mission Pharmacal Company – Key Employees 19
Mission Pharmacal Company – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Product News 22
May 03, 2016: Mission Pharmacal’s Lycelle Head Lice Removal Kit Is Now Available In Pharmacies 22
02/10/2016: Statement on Imprimis Pharmaceuticals Announcement Regarding Thiola 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Key Facts 2
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mission Pharmacal Company, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mission Pharmacal Company, Deals By Therapy Area, 2011 to YTD 2017 8
Mission Pharmacal Company, Medical Devices Deals, 2011 to YTD 2017 9
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Espada Dermatology Acquires GlyDerm from Lautus Pharma 11
Mission Pharmacal Acquires Eletone Cream From Ferndale Healthcare 12
DARA BioSciences Enters into Co-Promotion Agreement with Mission Pharmacal 13
Meda Enters Promotion Agreement With Mission Pharmacal For Elestrin 14
Retrophin Amends Licensing Agreement with Mission Pharmacal for Thiola 15
EffRx Pharma Enters Into Licensing Agreement With Mission Pharmacal For Binosto 16
Mission Pharmacal Acquires ProSolus Pharma 17
Mission Pharmacal Company, Key Competitors 18
Mission Pharmacal Company, Key Employees 19
Mission Pharmacal Company, Other Locations 20
Mission Pharmacal Company, Subsidiaries 20

★海外企業調査レポート[Mission Pharmacal Company-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jaiprakash Power Ventures Ltd (JPPOWER):電力:M&Aディール及び事業提携情報
    Summary Jaiprakash Power Ventures Ltd (Jaiprakash Power) is a power utility. It plans, develops, implements, and operates electric projects. The company produces electricity using hydro and coal sources. Jaiprakash Power also has development interests in the Hirong hydroelectric project and the Lowe …
  • ABPA Holdings Ltd:企業の戦略的SWOT分析
    ABPA Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Georgia Power Co:企業の戦略的SWOT分析
    Georgia Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • CommScope Holding Company Inc (COMM):企業の財務・戦略的SWOT分析
    CommScope Holding Company Inc (COMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tenet Healthcare Corp (THC)-製薬・医療分野:企業M&A・提携分析
    Summary Tenet Healthcare Corp (Tenet) is a health care services company that operates hospitals, diagnostic imaging centers, ambulatory surgery centers, and related health care facilities along with its subsidiaries and affiliates. It is one of the leading healthcare services companies in the US, wi …
  • Grant Thornton International Ltd.:戦略・SWOT・企業財務分析
    Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Genfit SA (GNFT):企業の財務・戦略的SWOT分析
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program …
  • KKR & Co Inc (KKR):企業の財務・戦略的SWOT分析
    KKR & Co Inc (KKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • NuStar GP Holdings LLC (NSH):企業の財務・戦略的SWOT分析
    Summary NuStar GP Holdings LLC (NuStar) is an oil and gas company that offers transportation and logistics services to petroleum products and anhydrous ammonia. The company offers services such as terminalling and storage of petroleum products, petroleum refining and marketing, and transportation of …
  • WB Electronics SA :企業の戦略・SWOT・財務情報
    WB Electronics SA - Strategy, SWOT and Corporate Finance Report Summary WB Electronics SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • iBio Inc (IBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Flex Foods Ltd:企業の戦略・SWOT・財務情報
    Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • McAlister’s Corporation:企業の戦略・SWOT・財務情報
    McAlister’s Corporation - Strategy, SWOT and Corporate Finance Report Summary McAlister’s Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mereo Biopharma Group Plc (MPH):企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Sourcenext Corp (4344):企業の財務・戦略的SWOT分析
    Sourcenext Corp (4344) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Bosch Rexroth AG:企業の戦略的SWOT分析
    Bosch Rexroth AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Angelo Iafrate Construction Co:企業の戦略・SWOT・財務情報
    Angelo Iafrate Construction Co - Strategy, SWOT and Corporate Finance Report Summary Angelo Iafrate Construction Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Baptist Memorial Health Care Corp:企業の戦略的SWOT分析
    Baptist Memorial Health Care Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Star Gas Partners L.P.:企業の戦略・SWOT・財務情報
    Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • U.S. Stem Cell Inc (USRM):製薬・医療:M&Aディール及び事業提携情報
    Summary U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆